We are pleased to share ASIPP will be in New Orleans, LA for its 23rd Annual Meeting June 24-26, 2021.

Join us for our first onsite national meeting for interventional pain physicians since the pandemic began. The meeting will be educational (providing much-needed CME credits), exciting, and will offer the long-awaited ability to leave our homes and attend meetings in person in a COVID-compliant environment.


Submission Deadline is May 10, 2021






Recorded versions of our virtual review courses are available to purchase. The following courses are offered:

Attendees Price
New Registration
Imaging Review Course$ 100$ 300
Controlled Substance Management$ 100$ 300
Documentation, Coding, Compliance, and Practice Management$ 100$ 300
Board Review Course$ 200$ 500


July 9-11, 2021GSIPP 17th Annual Pain SummitThe Cloister Hotel at Sea Island, GA
Aug 20-22, 2021Ohio and Kentucky Societies of Interventional Pain Physicians Annual MeetingThe Westin Cincinnati
21 E 5th Street
Cincinnati, OH 45202
Oct 15-17, 2021California Society of Interventional Pain Physicians Annual MeetingTerranea
100 Terranea Way
Rancho Palos Verdes, CA 90275

Click here to see more upcoming state society meetings!



Join ASIPP. Your Voice For Interventional Pain Management

New Nationwide Policy on Facet Joint Interventions!

Interventional pain management techniques in general, facet joint interventions, and epidural interventions in particular, have been in the news for the past year. There have been 2 reports from the Office of Inspector General (OIG) covering the frequency of therapeutic facet joint injections and another report from Noridian with only 49% of the claims meeting appropriateness criteria.

Based on the Cures Act to provide uniformity and transparency, new local coverage determinations (LCDs) have been established. Consequently, a multijurisdictional expert committee had hearings on potential coverages on the future for facet joint interventions in May 2020 and for epidural interventions in February 2021.



ASIPP is pleased to announce the publication of the Comprehensive Evidence-Based Guidelines for Epidural Interventions in the Management of Chronic Spinal Pain. In preparation of the guidelines, an extensive literature review was performed. The 210-page guidelines contains 33 figures, 48 tables, 1,345 references and has 60 authors.

In addition to the review of multiple manuscripts in reference to utilization, expenditures, anatomical and pathophysiological considerations, pharmacological and harmful effects of drugs and procedures, for evidence synthesis, we have included 47 systematic reviews and 43 RCTs covering all epidural.


The American Society of Interventional Pain Physicians has received numerous requests on potential guidance regarding the use of steroid injections during COVID-19 and specifically guidance on the use of steroids in injections, before and after being vaccinated. We are currently working on finalizing this document and would like to share the draft version with you. We will update you soon with the final version.

[ Click here for DRAFT DOCUMENT ]

Final rule gives providers access to patient treatment histories, and streamlines prior authorization to improve patient experience and alleviate burden for health care providers.


Placebo effect is fascinating, yet totally misunderstood and biased. A placebo is a substance or treatment, which is designed to have no therapeutic value. Essentially, it means an inert substance is injected into an inert structure through injection other than by mouth or sham surgery. The use of placebos in clinical medicine raises ethical concerns, especially if they are disguised as an active treatment, as this introduces dishonesty into the doctor-patient relationship and bypasses informed consent.


ASIPP announces process to claim third-round stimulus checks and extends support for COVID-19 Relief Legislation, advancing essential policies supporting patients and physicians


ASIPP this week sent seven comment letters to the following insurance providers regarding proposed rules that would hinder access of facet joint injections to patients. Click on the links below to read each letter.

CGS Administrators, LLC
First Coast Service Options, Inc.
National Government Services
Novitas Solutions, Inc.
Noridian Healthcare Solutions, LLC
Palmetto, GBA
Wisconsin Physician Services Insurance Corporation

Amniotic Tissue Intraarticular Injections

Many ASIPP members have recently been approached by sales representatives claiming that amniotic or umbilical cord tissue products are now covered by Medicare and many private insurers for intraarticular injections and interventional pain management procedures.

Based on collective evidence, unfortunately, these claims appear to be INACCURATE, subjecting patients and providers to high risk.

Amnion is covered for limited cutaneous wound healing applications and for a handful of neurosurgical and ophthalmic surgical uses, it has a product reimbursement code (also known as a Q code). If a physician submits the right combination of ICD-10 and CPT codes, Medicare may pay these claims.

Based on review of Medicare local coverage determination (LCD) documents, biologics for intraarticular injections and interventional pain management procedures are Experimental and Investigational. Hence, there is NO coverage for these products for intraarticular injections and interventional pain management procedures. 

It’s the recommendation of ASIPP that you avoid billing Medicare and private insurance for these products when used to treat orthopedic and pain management conditions. Our concern is that by billing these products to a federal program like Medicare, not only could there be significant Medicare clawbacks, but knowingly billing Medicare for products that you know are not covered can result in serious criminal penalties. Even, initial losses could be extensive.

For additional information on coverage guidelines from many private insurers that state that these products are NOT covered, experimental and investigational. Please check the websites of commercial carriers.

Pain Physician, the official journal of ASIPP, has launched a special issue covering COVID-19 issues. The publications range from understanding the pathophysiological mechanisms, epidemiology, implications on interventional pain practices, safety and effectiveness of various modalities of drug therapy, telemedicine, along with the effect on interventional pain management practices, and, finally, the technological impact of COVID-19 on the future of education and health care delivery and multiple guidelines.

Pain Physician published COVID-19 special issue with 18 original manuscripts and multiple letters. This issue includes an amazing editorial [ ]; 

Evidence-Based Risk Mitigation Strategies and Stratification during COVID-19 for Return to Interventional Pain Practices [ ], and Triaging Interventional Pain Procedures during COVID-19 or Related Elective Surgery Restrictions [ ]. 

Both manuscripts describe various means to continuation of the services at present, and also in future if there is a resurgence or in a worst-case scenario lock-down, and training and education during COVID epidemic. Other articles include Burnout among Pain Physicians, Implications on Interventional Pain Practice, and manuscripts on antibody testing, drug therapy, and stem cell therapy.


As you know, ASIPP has been in the forefront and continuing our advocacy to make telehealth permanent for all insurers and all payers. In addition, we have also been trying to keep telephone only at the same price as face-to-face or telehealth visits…

On behalf of ASIPP, we would like to remind members of additional financing, SBA disaster loan options, and the Employee Retention Credit Programs designed for economic relief for practices/businesses suffering economic losses from Covid-19. For those who may feel the PPP Loans/Medicare Advanced Payments are not enough to fund operations through the crisis, there is another SBA program that could help you.


There have been numerous changes since the CDC guidelines were first published. During this time, HHS Inter-Agency Task Force developed Pain Management Best Practices: Updates, Gaps, Inconsistencies, and Recommendations. This is an excellent document with significant importance to interventional pain management.


Manchikanti and 37 distinguished co-authors from multiple institutions have published “Comprehensive Evidence-based Guidelines for Facet Joint Interventions in Management of Chronic Spinal Pain


We received a letter from Tracy Richardson, Acting Director, Financial Services Group, Office of Financial Management, Centers for Medicare And Medicaid Services, addressed to ASIPP in reference to confirming their position on telehealth and duration of waivers.


Updated News on Stimulus, Telehealth, CAC Meeting, and Guidelines


The following is important information on the newly released 2020 payment rules. ASIPP and SIPMS will be sending comment letters to CMS in the near future. You may also send comment letters to them on these payment rules.



 Dr. Manchikanti discusses the 2021 ASIPP Annual Meeting (the first in-person meeting since 2019). 

Click Here To Register For The ASIPP Annual Meeting! You don’t want to miss it!

Please join the ASIPP Relief Fund in providing much needed aid to the COVID outbreak in India. Click here to read more! 

Doctor Finder allows you to search for an ASIPP® Member Interventional Pain Physician anywhere in America by name or by location. It’s quick and easy.

PainExam is proud to announce that it now offers preparation for the ABIPP Pain Management Board Exam! In addition, PainExam has now collaborated with ASIPP to offer Virtual Learning programs.


PainCast, the pain management network, has collected years worth of information on the history and processes of the pain management specialization and transformed it into a virtual library of videos, journals, articles, podcasts, and more – all at your fingertips.

A Second Wave of Coronavirus. Neil Cavuto and Dr. Devi Nampiaparampil discuss a possible second wave of coronavirus this winter.


Essentials of Regenerative Medicine in Interventional Pain Management is a book to bring concise, collective, and comprehensive information to interventional pain physicians practicing regenerative medicine with its applications in managing chronic pain.


ASIPP has formed a partnership with Henry Schein and PedsPal, a national GPO that has a successful history of negotiating better prices on medical supplies and creating value added services for the independent physician.


The American Society of Interventional Pain Physicians (ASIPP) is pleased to announce a partnership with Willow Risk Advisors to create an exclusive policy available to ASIPP members. In an effort to further increase value to its physician members, the American Society of Interventional Pain Physicians (ASIPP) has endorsed Willow Risk Advisors as their professional liability insurance broker.


ASIPP is now offering our members the benefit of a unique revenue cycle management/billing service. We have received a tremendous amount of interest in the ASIPP billing and coding program.